Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

Clinical and Experimental Metastasis

Volumn 27, Issue 8, 2010, Pages 557-569

  Chen, Hongmin ^a,b   Wang, Li ^a,b   Beretov, Julia ^b,c   Hao, Jingli ^b,c   Xiao, Weiwei ^b,c   Li, Yong ^b,c  

^a Henan Provincial Cancer Hospital   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

CD147 EMMPRIN; Epithelial ovarian cancer; MCTs; Metastasis; Multiple drug resistance proteins

Indexed keywords

CD147 ANTIGEN; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; EPITHELIAL OVARIAN CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MULTIDRUG RESISTANCE; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; ANTIGENS, CD147; BLOTTING, WESTERN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUSCLE PROTEINS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; SYMPORTERS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 78649327877     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9345-9     Document Type: Article

References (45)

1. RD Baird SB Kaye 2003 Drug resistance reversal-are we getting closer? Eur J Cancer 39 2450 2561 1:CAS:528:DC%2BD3sXos1Kis7c%3D 10.1016/S0959-8049(03) 00619-1 14602131 (Pubitemid 37340159)
2. L Yan S Zucker BP Toole 2005 Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression Thromb Haemost 93 199 204 1:CAS:528:DC%2BD2MXhs1Kgu7w%3D 15711733
3. SM Gallagher JJ Castorino D Wang NJ Philp 2007 Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231 Cancer Res 67 4182 4189 1:CAS:528:DC%2BD2sXltVyrs74%3D 10.1158/0008-5472.CAN-06-3184 17483329 (Pubitemid 46815064)
4. MG Slomiany GD Grass AD Robertson XY Yang BL Maria C Beeson BP Toole 2009 Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells Cancer Res 69 1293 1301 1:CAS:528:DC%2BD1MXhslynsr8%3D 10.1158/0008-5472.CAN-08-2491 19176383
5. R Martinez-Zaguilan EA Seftor RE Seftor YW Chu RJ Gillies MJ Hendrix 1996 Acidic pH enhances the invasive behavior of human melanoma cells Clin Exp Metastasis 14 176 186 1:CAS:528:DyaK28XitlKnsLY%3D 10.1007/BF00121214 8605731 (Pubitemid 26074280)
6. O Tredan CM Galmarini K Patel IF Tannock 2007 Drug resistance and the solid tumor microenvironment J Natl Cancer Inst 99 1441 1454 1:CAS:528:DC%2BD2sXht1yltbrO 10.1093/jnci/djm135 17895480
7. J Fang QJ Quinones TL Holman MJ Morowitz Q Wang H Zhao F Sivo JM Maris ML Wahl 2006 The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma Mol Pharmacol 70 2108 2115 1:CAS:528:DC%2BD28Xht1ylt7jN 10.1124/mol.106.026245 17000864 (Pubitemid 44771926)
8. MK Froberg DZ Gerhart BE Enerson C Manivel M Guzman-Paz N Seacotte LR Drewes 2001 Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues Neuroreport 12 761 765 1:CAS:528: DC%2BD3MXisVygsbk%3D 10.1097/00001756-200103260-00030 11277580
9. MI Koukourakis A Giatromanolaki AL Harris E Sivridis 2006 Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma Cancer Res 66 627 632 10.1158/0008-5472.CAN-05-3260 (Pubitemid 43165922)
10. P Kirk MC Wilson C Heddle MH Brown AN Barclay AP Halestrap 2000 CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression EMBO J 19 3896 3904 1:CAS:528:DC%2BD3cXmsVKqur4%3D 10.1093/emboj/19.15.3896 10921872
11. UA Germann 1996 P-glycoprotein-a mediator of multidrug resistance in tumour cells Eur J Cancer 32A 927 944 1:CAS:528:DyaK28XksVOnt78%3D 10.1016/0959-8049(96)00057-3 8763334
12. GD Kruh MG Belinsky 2003 The MRP family of drug efflux pumps Oncogene 22 7537 7752 1:CAS:528:DC%2BD3sXotlaju7Y%3D 10.1038/sj.onc.1206953 14576857 (Pubitemid 37487175)
13. M Kool M de Haas GL Scheffer RJ Scheper MJ van Eijk JA Juijn F Baas P Borst 1997 Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance associated protein gene (MRP1), in human cancer cell lines Cancer Res 57 3537 3547 1:CAS:528:DyaK2sXls1Sgsr0%3D 9270026
14. P Surowiak V Materna I Kaplenko M Spaczynski B Dolinska-Krajewska E Gebarowska M Dietel M Zabel H Lage 2006 ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome Clin Cancer Res 12 7149 7158 1:CAS:528: DC%2BD28Xht1Kns7bI 10.1158/1078-0432.CCR-06-0564 17145840 (Pubitemid 44974516)
15. H Yang W Zou Y Li B Chen X Xin 2007 Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells Cancer Biol Ther 6 942 947 1:CAS:528:DC%2BD2sXht1yktrbO 10.1158/1535-7163.MCT-06-0557 17611393 (Pubitemid 46332464)
16. J Su X Chen T Kanekura 2009 A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis Cancer Lett 273 140 147 1:CAS:528: DC%2BD1cXhsVWnu7vF 10.1016/j.canlet.2008.07.034 18778892
17. W Schneiderhan M Scheler KH Holzmann M Marx JE Gschwend M Bucholz TM Gress T Seufferlein G Adler F Oswald 2009 CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models Gut 58 1391 1398 1:CAS:528:DC%2BD1MXhtlSks7bM 10.1136/gut.2009.181412 19505879
18. WJ Creasman 1998 Announcement, FIGO stages: 1988 revisions Gynecol Oncol 5 125 127
19. AA Deora N Philp J Hu D Bok E Rodriguez-Boulan 2005 Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia Proc Natl Acad Sci USA 102 16245 16250 1:CAS:528:DC%2BD2MXht1Cgur3I 10.1073/pnas.0504419102 16260747 (Pubitemid 41688899)
20. S Misra S Ghatak BP Toole 2005 Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2 J Biol Chem 280 20310 20315 1:CAS:528:DC%2BD2MXktlCmurw%3D 10.1074/jbc.M500737200 15784621 (Pubitemid 40776728)
21. W Zou H Yang X Hou W Zhang B Chen X Xin 2007 Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells Cancer Lett 248 211 218 1:CAS:528:DC%2BD2sXisVWmtbk%3D 10.1016/j.canlet.2006.07.005 16930823 (Pubitemid 46330554)
22. YH Kuang X Chen J Su LS Wu J Li J Chang Y Qiu ZS Chen T Kanekura 2008 Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing J Proteome Res 7 4784 4791 1:CAS:528:DC%2BD1cXhtFGktrzO 10.1021/pr800355b 18816083
23. L Jia W Wei J Cao H Xu X Miao J Zhang 2009 Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells Ann Hematol 88 753 760 1:CAS:528:DC%2BD1MXntlSgsbs%3D 10.1007/s00277-008- 0678-2 19125248
24. B Davidson I Goldberg A Berner GB Kristensen R Reich 2003 EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma Clin Exp Metastasis 20 161 169 1:CAS:528:DC%2BD3sXhslOkt74%3D 10.1023/A:1022696012668 12705637 (Pubitemid 36403281)
25. D Millimaggi M Mari S D'Ascenzo E Carosa EA Jannini S Zucker G Carta A Pavan V Dolo 2007 Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells Neoplasia 9 349 357 1:CAS:528: DC%2BD2sXkvVWgsr0%3D 10.1593/neo.07133 17460779 (Pubitemid 46608302)
26. JS Jin CW Yao SH Loh MF Cheng DS Hsieh CY Bai 2006 Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters Int J Gynecol Pathol 25 140 146 10.1097/01.pgp.0000189244.57145.84 16633062 (Pubitemid 44620175)
27. S Sillanpaa M Anttila K Suhonen K Hamalainen T Turpeenniemi-Hujanen U Puistola M Tammi R Sironen S Saarikoski VM Kosma 2007 Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer Tumour Biol 28 280 289 1:CAS:528:DC%2BD2sXhtlCgsbbO 10.1159/000110426 17962725 (Pubitemid 350165834)
28. RA Gatenby RJ Gillies 2004 Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 891 899 1:CAS:528:DC%2BD2cXptFegt7w%3D 10.1038/nrc1478 15516961 (Pubitemid 39472955)
29. H Izumi T Torigoe H Ishiguchi H Uramoto Y Yoshida M Tanabe T Ise T Murakami T Yoshida M Nomoto K Kohno 2003 Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy Cancer Treat Rev 29 541 549 1:CAS:528:DC%2BD3sXosVygt7g%3D 10.1016/S0305-7372(03)00106-3 14585264 (Pubitemid 37428326)
30. C Pinheiro A Longatto-Filho C Scapulatempo L Ferreira S Martins L Pellerin M Rodrigues VA Alves F Schmitt F Baltazar 2008 Increased expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas Virchows Arch 452 139 146 1:CAS:528:DC%2BD1cXhs1Wntrw%3D 10.1007/s00428-007-0558-5 18188595
31. C Pinheiro A Longatto-Filho L Ferreira SM Pereira D Etlinger MA Moreira LF Jube GS Queiroz F Schmitt F Baltazar 2008 Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma Int J Gynecol Pathol 27 568 574 10.1097/PGP.0b013e31817b5b40 18753962
32. MI Koukourakis A Giatromanolaki G Bougioukas E Sivridis 2007 Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma Cancer Biol Ther 6 1476 1479 1:CAS:528: DC%2BD1cXhtlCitbk%3D 10.4161/cbt.6.9.4635 17881895
33. C Pinheiro A Longatto-Filho K Simoes CE Jacob CJ Bresciani B Zilberstein I Cecconello VA Alves F Schmitt F Baltazar 2009 The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer Euro J Cancer 45 2418 2424 1:CAS:528:DC%2BD1MXhtVegs77F 10.1016/j.ejca.2009.06.018
34. H Xing S Wang D Weng G Chen X Yang J Zhou G Xu Y Lu D Ma 2007 Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids Oncol Reports 17 117 122 1:CAS:528:DC%2BD2sXhtFagtL4%3D
35. RT Penson E Oliva SJ Skates T Glyptis AF Fuller Jr A Goodman MV Seiden 2004 Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples Gynecol Oncol 93 98 106 1:CAS:528:DC%2BD2cXisFyltbc%3D 10.1016/j.ygyno.2003.11.053 15047220 (Pubitemid 38429555)
36. V Materna J Pleger U Hoffmann H Lage 2004 RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, trans and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response Gynecol Oncol 94 152 160 1:CAS:528:DC%2BD2cXlslOqtr0%3D 10.1016/j.ygyno.2004.03.035 15262134 (Pubitemid 38950512)
37. Y Yokoyama S Sato Y Fukushi T Sakamoto M Futagami Y Saito 1999 Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer J Obstet Gynaecol Res 25 387 394 1:CAS:528:DC%2BD3cXhtFSgtr8%3D 10.1111/j.1447-0756.1999.tb01182.x 10680335
38. SS Ozalp OT Yalcin M Tanir S Kabukcuoglu E Etiz 2002 Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies Eur J Gynaecol Oncol 23 337 340 1:STN:280:DC%2BD38vls1eitQ%3D%3D 12214739
39. H Chen JL Hao L Wang Y Li 2009 Coexpression of invasive markers (uPA, CD44) and multiple drug resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression Br J Cancer 101 432 440 1:CAS:528:DC%2BD1MXpsVKnu70%3D 10.1038/sj.bjc.6605185 19603017
40. V Materna B Liedert J Thomale H Lage 2005 Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells Int J Cancer 115 393 402 1:CAS:528: DC%2BD2MXkt1Clurw%3D 10.1002/ijc.20899 15688364 (Pubitemid 40663743)
41. JJ Ma BL Chen XY Xin 2009 Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene Arch Gynecol Obstet 279 149 157 1:CAS:528:DC%2BD1MXmtVOh 10.1007/s00404-008-0690-8 18584188
42. J Xu HY Xu Q Zhang F Song JL Jiang XM Yang L Mi N Wen R Tian L Wang H Yao Q Feng Y Zhang JL Xing P Zhu ZN Chen 2007 HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma Mol Cancer Res 5 605 614 1:CAS:528:DC%2BD2sXmsF2nsLY%3D 10.1158/1541-7786.MCR-06-0286 17579119 (Pubitemid 46985049)
43. NR Dean JR Newman EE Helman W Zhang S Safavy DM Weeks M Cunningham LA Snyder Y Tang L Yan LR McNally DJ Buchsbaum EL Rosenthal 2009 Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer Clin Cancer Res 15 4058 4065 1:CAS:528:DC%2BD1MXntlOisL8%3D 10.1158/1078-0432.CCR-09- 0212 19509148
44. H Matsudaira T Asakura K Aoki Y Searashi T Matsuura H Nakajima H Tajiri K Ohkawa 2010 Target chemotherapy of anti-CD147 antibody-labeled liposome encapsulated GSH-DXR conjugate on CD147 highly expressed carcinoma cells Int J Oncol 36 77 83 1:CAS:528:DC%2BC3cXmvVWquw%3D%3D 19956835
45. P Sonveaux F Vegran T Schroeder MC Wergin J Verrax ZN Rabbani CJ De Saedeleer KM Kennedy C Diepart BF Jordan MJ Kelley B Gallez ML Wahl O Feron MW Dewhirst 2008 Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice J Clin Invest 118 3930 3942 1:CAS:528:DC%2BD1cXhsVKgu7rI 19033663